Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
A straightforward rationale for incorporating Equal Weighted Indices into a portfolio, emphasizing diversification and simplicity.
22,501 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Investors are weighing the latest earnings from First Majestic Silver. This article breaks down what the numbers mean...
A dramatic May surge can lure investors, but this glorious growth stock may face headwinds in June. This guide explai...
Political wrangling and funding gaps create a tightening knot for Social Security. This article explains the math, th...
When an investment firm Absoluto Partners reveals a fresh stake in MercadoLibre, traders take note. This in-depth gui...
Palantir's journey has been a roller coaster—massive gains, sharp pulls, and ongoing questions. This guide distills w...
Housing costs and fuel prices are digitizing the inflation picture. This article explains how shelter gasoline pushed...
A new space-focused ETF is turning heads with strong gains this year. While SpaceX IPO excitement helps, the fund’s b...
Two AI giants, Microsoft and Nvidia, offer very different routes to growth. This guide breaks down why one might fit ...
Looking for cash flow that lasts through retirement without chasing risky yields? Meet two resilient dividend stalwar...
Is GE Vernova the vernova smartest investment make for your portfolio? This comprehensive guide breaks down the busin...
Could XRP break the $5 barrier by 2026? This article breaks down the drivers, timelines, and practical steps for inve...